Wingard DL, Barrett-Connor E (1995) Heart disease and diabetes. Diabetes Am 2(1):429–448
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39(7):1151–1158
Auerbach MA, Schöder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, Silverman D, Phelps ME, Schelbert HR, Czernin J (1999) Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 99(22):2921–2926
Article CAS PubMed Google Scholar
Valenta I, Quercioli A, Ruddy T, Schindler TH (2013) Assessment of myocardial viability after the STICH trial: still viable? Cardiovasc Med 16(11):289–298
Gropler RJ, Siegel BA, Lee KJ, Moerlein SM, Perry DJ, Bergmann SR, Geltman EM (1990) Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 31(11):1749–1756
Gandoy-Fieiras N, Gonzalez-Juanatey JR, Eiras S (2020) Myocardium metabolism in physiological and pathophysiological states: implications of epicardial adipose tissue and potential therapeutic targets. Int J Mol Sci 21(7):2641
Article CAS PubMed PubMed Central Google Scholar
Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ (2009) ASNC imaging guidelines for nuclear cardiology procedures: PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol 16(4):651
Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI (2016) ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 23(5):1187–1226
Soares J, Rodrigues Filho F, Izaki M, Giorgi MC, Catapirra RM, Abe R, Vinagre CG, Cerri GG, Meneghetti JC (2014) Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18 F-fluorodeoxyglucose-PET: a pilot study. Int J Cardiovasc Imaging 30:415–423
Schinkel AF, Bax JJ, Valkema R, Elhendy A, van Domburg RT, Vourvouri EC, Bountioukos MA, Krenning EP, Roelandt JR, Poldermans D (2003) Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med 44(6):877–883
Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Häkönen R, Ahonen A, Teräs M, Haaparanta M, Wegelius U, Haapanen A, Hartiala J (1992) Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 33(7):1255–1262
Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS (2001) Myocardial glucose utilization and optimization of 18F-FDG PET imaging in patients with non–insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med 42(12):1730–1736
Shao X, Chen Y, Chen Y, Zhang F, Zhou M, Niu R, Wang Y (2021) Feasibility and application of trimetazidine in 18F-FDG PET myocardial metabolic imaging of diabetic mellitus patients with severe coronary artery disease: A prospective, self-controlled study. J Nucl Cardiol 30:1–1
Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH (2007) Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32(7):375–410
Wu YW, Tadamura E, Yamamuro M, Kanao S, Marui A, Tanabara K, Komeda M, Togashi K (2007) Comparison of contrast-enhanced MRI with 18F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med 48(7):1096–1103
Gould GW, Holman GD (1993) The glucose transporter family: structure, function and tissue-specific expression. Biochem J 295(Pt 2):329
Article CAS PubMed PubMed Central Google Scholar
Abel ED (2004) Glucose transport in the heart. Front Biosci 9(1):201–215
Article CAS PubMed Google Scholar
Berry JJ, Baker JA, Pieper KS, Hanson MW, Hoffman JM, Coleman RE (1991) The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. J Nucl Med 32(8):1518–1525
Hicks RJ, Herman WH, Kalff V, Molina E, Wolfe ER, Hutchins G, Schwaiger M (1991) Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol 18(1):101–111
Article CAS PubMed Google Scholar
Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A (2018) Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the translational research committee of the heart failure association-european society of cardiology. Eur Heart J 39(48):4243–4254
Article CAS PubMed PubMed Central Google Scholar
Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol 17(9):585–607
Article PubMed PubMed Central Google Scholar
Mhlanga J, Derenoncourt P, Haq A, Bhandiwad A, Laforest R, Siegel BA, Dehdashti F, Gropler RJ, Schindler TH (2022) 18F-FDG PET in myocardial viability assessment: a practical and time-efficient protocol. J Nucl Med 63(4):602–608
Article CAS PubMed Google Scholar
Chen YC, Wang QQ, Wang YH, Zhuo HL, Dai RZ (2020) Intravenous regular insulin is an efficient and safe procedure for obtaining high-quality cardiac 18F-FDG PET images: an open-label, single-center, randomized controlled prospective trial. J Nucl Cardiol 12:1–9
Chen YC, Pan MJ, Wang QQ, Wang YH, Zhuo HL, Dai RZ (2022) Intravenous insulin injection supplemented with subsequent milk consumption is a safer formulation for cardiac viability 18F-FDG imaging. J Nucl Cardiol 29(4):1985–1991
Comments (0)